Ultrasound Systems Market Analysis and Value Forecast Snapshot by End-Use Industry 2017-2022

Due to the increasing adoption of advanced imaging systems in healthcare industry, ultrasound systems continue to be an irreplaceable commodity. In the view of rising healthcare costs, affordable and accurate imaging & diagnosis achieved through ultrasound technology will continue to attract patients, and render profits even in conventional medical settings. Fact.MR’s report on the global market for ultrasound systems projects a steady growth for the market during 2017-2022. The global ultrasound systems market, which is pegged to reach US$ 6 Bn by 2017-end, will soar steadily at a 5.5% CAGR to reach US$ 7.8 Bn towards the end of 2022.

In this ultrasound systems market study, the following years are considered to project the market footprint:

• History Year: 2012-2016


• Base Year: 2012


• Estimated Year: 2022


• Forecast Year: 2017 – 2022

After reading the ultrasound systems market report, readers can:

• Understand the drivers, restraints, opportunities and trends affecting the growth of the global ultrasound systems market.


• Analyze key regions holding significant share of the total ultrasound systems market revenue.


• Study the growth outlook of the global ultrasound systems market scenario, including production, consumption, history and forecast.


• Learn consumption pattern and impact of each end use on the ultrasound systems market growth.


• Investigate the recent R&D projects performed by each ultrasound systems market player.

The ultrasound systems market report covers the following regions:

• MEA (South Africa, Nigeria)


• APEJ (Malaysia, Thailand)


• Europe (Spain. Italy)


• Latin America (Brazil, Mexico)

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=60

On the basis of technology, the ultrasound systems market report considers the following segments:

• 3D & 4D Ultrasound


• Doppler Ultrasound


• High-intensity Focused Ultrasound


• Extracorporeal Shockwave Lithotripsy

On the basis of application, the ultrasound systems market report includes:

• Cardiology


• Radiology


• Urology


• Vascular


• Gynecology

Prominent ultrasound systems market players covered in the report contain:

• General Electric Company


• Koninklijke Philips N.V..


• Toshiba Corporation


• Siemens AG


• Fujifilm Holdings Corporation


• Esaote SpA


• Shimadzu Corporation


• Analogic Corporation


• Samsung Electronics Co. Ltd


• Hitachi Ltd

The behavior pattern of each player – new product launches, partnerships, and acquisitions – has been analyzed in the ultrasound systems market report comprehensively. In addition, the research encompasses the strengths, weaknesses, opportunities and threats of each ultrasound systems market vendor in an in-depth manner.

The ultrasound systems market report answers important questions which include:

• What does the status of the ultrasound systems market look like after the forecast period?


• Which region has the highest contribution to the global ultrasound systems market and why?


• Which players remain at the top of the global ultrasound systems market?


• What opportunities are available for the ultrasound systems market players to expand their production footprint?


• Which segment has the maximum impact on the global ultrasound systems market?

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=60

Why Opt For Fact.MR?

1. Various analysis methods to deliver precise market information.


2. Digital technologies to facilitate clients with updated market solutions.


3. Multi-disciplinary approach to provide accurate insights of different industries.


4. Data collection from extensive primary and secondary research.


5. Round-the-clock availability to serve clients across the world.

Phototherapy Devices Market Report Examines Top Company Analysis Forecast by 2022

Phototherapy devices are used for treating neonatal jaundice and various skin conditions. These devices are extensively used in procedures such as reducing of bilirubin serum concentration or curing bilirubin toxicity. Phototherapy devices are also used in treating hyperbilirubinemia in both haemolytic and non-hemolytic conditions. These devises can effectively reduce the need for frequent blood transfusion. Phototherapy devices are facilitating greater patient convenience and hence witnessing widespread adoption in hospitals and clinics.

Majority of phototherapy device manufacturers are actively focusing on raising the standards of medical technology in skin disease treatment. Rising concerns over severe skin ailments and introduction of advanced phototherapy treatments is facilitating the growth of the global phototherapy device market. A recent report by Fact.MR provides in-depth analysis of the global phototherapy devices market for the forecast period 2017-2022, and offers pragmatic insights to lead market players towards devising & implementing informed strategies. 

In this phototherapy devices market study, the following years are considered to predict the market footprint:

• History Year: 2012-2016


• Base Year: 2012


• Estimated Year: 2022


• Forecast Year: 2017 – 2022

The business intelligence study of the phototherapy devices market covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). In a bid to recognize the growth prospects in the phototherapy devices market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market. Each segment of the phototherapy devices market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:

• MEA (Nigeria, South Africa)


• APEJ (Singapore, Australia)


• Europe (Italy, Spain)


• Latin America (Brazil, Mexico)

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=76

The key players in the global phototherapy devices market report consist of

• General Electric Company


• Drägerwerk AG & Co. KGaA


• Medela AG


• Hill-Rom


• Natus Medical Incorporated


• The Daavlin Company


• Solarc Systems Inc.


• Schulze & Böhm GmbH


• Guangzhou Beautylife Electronic Technology co.,Ltd


• Medisana AG


• Herbert Waldmann GmbH & Co. KG


• National Biological Corp.


• Philips Lighting Holding B.V.


• Phoenix Medical Systems Pvt. Ltd.


• Nice Neotech Medical Systems Pvt. Ltd.


• NINGBO DAVID MEDICAL DEVICE CO., LTD.


• ALFAMEDIC S.R.O.


• Heal Force Bio-Meditech Holdings Limited


• DIXION


• Natus Medical Incorporated

Each market player encompassed in the phototherapy devices market study is assessed according to its market share, production footprint, current launches, agreements, ongoing R&D projects, and business tactics. In addition, the phototherapy devices market study scrutinizes the strengths, weaknesses, opportunities and threats (SWOT) analysis.

On the basis of product type, the global phototherapy devices market report covers the footprint, and consumption of the segments including

• Conventional Phototherapy Devices


• Fiber Optic Phototherapy Devices

The global phototherapy devices market covers the demand trends of each end user which includes

• Hospitals


• Dermatology Clinics


• Home Care Settings

What insights readers can gather from the phototherapy devices market report?

• A critical study of the phototherapy devices market on the basis of product, end user and region.


• Learn the behavior pattern of every phototherapy devices market player – product launches, expansions, collaborations and acquisitions in the market currently.


• Examine and study the progress outlook of the global phototherapy devices market landscape, which includes, revenue, production & consumption and historical & forecast.


• Understand important drivers, restraints, opportunities, and trends (DROT Analysis).


• Important trends, such as carbon footprint, R&D developments, prototype technologies, and globalization.

The phototherapy devices market report answers the following queries:

1. Which players hold the significant phototherapy devices market share and why?


2. What strategies are the phototherapy devices market players forming to gain a competitive edge?


3. Why region is expected to lead the global phototherapy devices market?


4. What factors are negatively affecting the phototherapy devices market growth?


5. What will be the value of the global phototherapy devices market by the end of 2022?

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=76

Why Choose Fact.MR?

1. Deliver updated information on the current industry trends


2. Available 24/7 to facilitate clients with unbiased solutions


3. Embrace digital technologies to offer accurate business ideas


4. Exhaustive supply chain augmentation analysis


5. Provide reports strictly according to the requirements of the clients

Drug Eluting Balloon Catheter Market Size, Trends and Cost with Global Forecast by 2022

Drug eluting balloon catheter is witnessing robust adoption owing to its overwhelming results in cardiovascular and peripheral artery procedures. Moreover, drug eluting balloon catheter is also turning out to be useful for patients who are unable to undergo percutaneous coronary intervention (PCI) procedures. Encouraged by this situation, various drug eluting balloon catheter manufacturers across the globe are now increasing their production capacity. The aforementioned factors are reflecting favourably on the global sales of the drug eluting balloon catheter.

Also, companies are aiming to manufacture cost-effective catheters that in order to increase market penetration. Growing prevalence of cardiovascular diseases and soaring incidences of cardiology intervention procedures is facilitating the growth of the global drug eluting balloon catheter market. Fact.MR projects that the global market for drug eluting balloon catheter will surge at a robust CAGR between 2018 and 2022.

In addition, factors such as enhanced reimbursement policies, rising geriatric population and growing healthcare expenditure are anticipated to positively impact the market’s growth. The arrival of new-generation drug eluting balloon catheters as well as heavier investments in R&D pipelines in order to increase its utility is also anticipate to create lucrative growth opportunities for manufacturers and stakeholder in the global market for drug eluting balloon catheter.

The drug eluting balloon catheter market report highlights the following players:

• Biotronik


• Cordis Corporation


• Cardionovum GmbH.


• Cook Medical Inc.


• Biosensors International Ltd.


• Tokai Medical Products Inc.


• Abbott Laboratories


• Hexacath


• Meril Life Pvt. Ltd.


• QX Medical LLC


• Jotech GmbH


• Braun Melsungen AG


• MicroPort Scientific Corporation


• Terumo Corporation


• Medtronic


• Boston Scientific Inc.

The drug eluting balloon catheter market report examines the operating pattern of each player – new product launches, partnerships, and acquisitions – has been examined in detail.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=146

Important regions covered in the drug eluting balloon catheter market report include:

• MEA (South Africa, Nigeria)


• APEJ (Singapore, Australia)


• Europe (Germany, France)


• Latin America (Mexico, Argentina)

The drug eluting balloon catheter market report takes into consideration the following segments by raw material:

• Polyurethane


• Nylon

The drug eluting balloon catheter market report contain the following end uses:

• Coronary Artery Disease


• Peripheral Vascular Disease

The drug eluting balloon catheter market report offers a plethora of insights which include:

• Changing consumption pattern among individuals globally.


• Historical and future progress of the global drug eluting balloon catheter market.


• Region-wise and country-wise segmentation of the drug eluting balloon catheter market to understand the revenue, and growth lookout in these areas.


• Accurate Year-on-Year growth of the global drug eluting balloon catheter market.


• Important trends, including proprietary technologies, ecological conservation, and globalization affecting the global drug eluting balloon catheter market.

The drug eluting balloon catheter market report answers important questions which include:

• Which regulatory authorities have granted approval to the application of drug eluting balloon catheter market in healthcare industry?


• How will the global drug eluting balloon catheter market grow over the forecast period?


• Which end use industry is set to become the leading consumer of drug eluting balloon catheter market by 2022?


• What manufacturing techniques are involved in the production of the drug eluting balloon catheter market?


• Which regions are the drug eluting balloon catheter market players targeting to channelize their production portfolio?

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=146

The drug eluting balloon catheter market report considers the following years to predict the market growth:

• Historic Year: 2012-2016


• Base Year: 2012


• Estimated Year: 2022


• Forecast Year: 2017 – 2022

Why Choose Fact.MR?

Fact.MR follows a multi- disciplinary approach to extract information about various industries. Our analysts perform thorough primary and secondary research to gather data associated with the market. With modern industrial and digitalization tools, we provide avant-garde business ideas to our clients. We address clients living in across parts of the world with our 24/7 service availability.

Patient Temperature Management Systems Market Share, Trends, Business Strategy

Patient temperature management systems have become a necessary part of several types of medical treatments. For example, patient temperature management systems are used in surgeries to prevent excessive blood loss and for a rapid recovery post-surgery. In some cases such as heart surgeries, the body heat of a patient is reduced, which is done through the process of blood cooling and this done for reducing surgical complications.

Even for patients undergoing treatment for cancer, patient temperature management systems are used to raise the body temperature for effective and efficient chemotherapy or radiation therapy procedures. Patient temperature management systems are also used in neonatal care, where in order to reduce body temperature fluctuations in new born babies, they are kept in incubators. With a going number of surgeries throughout the world, the market for patient temperature management systems is increasing manifold. However, the high cost associated with patient temperature management systems may hamper the market growth.

The global patient temperature management systems market is slated to touch a value of nearly US$ 2,860 Mn in the year 2022 and grow at a steady CAGR during the assessment period.

Competitive Assessment

The patient temperature management systems market report includes global as well as emerging players:

• 3M Company


• Asahi Kasei Corporation


• Stryker Corporation


• Smiths Medical


• Medtronic Plc


• Inspiration Healthcare Group plc


• R. Bard, Inc.


• Gentherm Incorporated

The insights for each vendor consists of:

• Company profile


• SWOT analysis


• Main market information


• Market share


• Revenue, pricing and gross margin

Regional Analysis

Important regions covered in the patient temperature management systems market report include:

• MEA (South Africa, Nigeria)


• APEJ (Singapore, Australia)


• Europe (Spain, Italy)


• Latin America (Mexico, Argentina)


• North America (U.S., Canada)

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=171

The patient temperature management systems market report also provides data regarding the key countries in the defined regions.

Segmentation Analysis

By Product:

• Perioperative Care


• Emergency Care


• Neonatal Care


• Acute Care

By end user:

• Hospitals


• Ambulatory Surgical Centers


• Neonatal Care Units


• Specialized Clinics

What insights does the patient temperature management systems market report provide to the readers?

• Patient temperature management systems market fragmentation on the basis of product type, end use, and region.


• Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.


• Collaborations, R&D projects, acquisitions, and product launches of each patient temperature management systems market player.


• Various regulations imposed by the governments on the consumption of patient temperature management systems market in detail.


• Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global patient temperature management systems market.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=171

Questionnaire answered in the patient temperature management systems market report include:

• How the market for patient temperature management systems market has grown over the historic period of 2012-2016?


• What is the present and future outlook of the global patient temperature management systems market on the basis of region?


• What are the challenges and opportunities for the patient temperature management systems market?


• Why the consumption of patient temperature management systems market highest in region?


• In which year segment is expected to overtake segment?

Peptide Based Metabolic Disorders Therapeutics Market In-depth Analysis and Insights

At present, the global peptide based metabolic disorders therapeutics market is confidently impacted by issues such as safety, efficacy, innovations in drug discovery, stability, easy synchronization, etc. Furthermore, the rate of investment in the healthcare industry merge with technological advancements and rise in biotech dealing with peptides to positively drive the global peptide based metabolic disorders therapeutics market. For deeper insights, Fact.MR has published a new report titled “Peptide Based Metabolic Disorders Therapeutics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022”, which meticulously states prime market factors including trends, opportunities and market share statistics covering diverse regional spaces. In addition, readers can be thoroughly enlightened with the availability of information associated to supply chain, Y-o-Y growth and market share comparison.

According to research specifics, the global peptide based metabolic disorders therapeutics market is predicted to exhibit more than US$ 8 Bn and likely to bolster at a vigorous rate during the forecast period. This assessment functions as a favorable data source for investors and new entrants to plan future strategies. The report is diligently bifurcated on the basis of drug type, distribution channel and region, where each segment is examined in terms of revenue (US$ Mn) comparison, Y-o-Y growth and market share comparison.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=187

Higher Traction from Hospital Pharmacies to Reinforce Revenue Share

According to this Fact.MR study, hospital pharmacies segment is projected to exhibit higher market share in terms of revenue during the period until 2022. However, there is an estimation that the target segment might lose BPS by the end of the forecast period. Moreover, retail pharmacies segment acquires second spot while focusing at market share by revenue; it displays a higher growth rate as compared to hospital pharmacies segment. Interestingly, online pharmacies segment is investigated as the fastest growing segment on the basis of distribution channel, and is predicted to register 11.8% CAGR during the period of forecast.

Liraglutide Drug Segment Conveys Enhanced Domination

Presenting a brief viewpoint of the global peptide based metabolic disorders therapeutics market, it has been examined that liraglutide segment by drug class portrays a higher market share by revenue. The report imparts vital statistics highlighting the market share of this particular segment ranking more than two and a half times as compared to exenatide segment. However, the growth of liraglutide segment is noted to be slow in comparison to the growth rates of the exenatide and others segments, reports Fact.MR.

North America Market Performance Set to Inflate during Forecast Period

The geographical vastness of the global peptide based metabolic disorders therapeutics market has been carefully inspected through this assessment. It has been recorded that North America would showcase the highest CAGR growth rate of 10.6% during the forecast period. This development scenario can be accredited to technological developments as well as higher investments across the healthcare industry which is motivating the North American market to state its domination by the end of 2022.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=187

Finally, this report mentions the leading players operating in the global market for peptide based metabolic disorders therapeutics and outline their contributions towards the advancement of this sector. Some of the leading players included in the report are Bachem Holding AG, Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Novo Nordisk A/S, PolyPeptide Group, Ipsen S.A, Eli Lilly, and Company, Merck & Co., Inc., and CordenPharma International.